ArticleAnnals of medicine and surgery (2012)2026
Exploring advancements in the management of penile cancer in the era of artificial intelligence and machine learning: a narrative review.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of review: This review aims to explore the current state of literature on the use of artificial intelligence (AI) in the management of penile cancer. We examined the various applications of AI in penile cancer, including but not limited to image identification, prediction of treatment results, and patient risk stratification. The review evaluates the current limitations and challenges faced in the implementation of AI in penile cancer management. Recent findings: The present literature emphasized the use of AI using radiomics and pathomics for management strategies and outcomes. Summary: AI has the power to shape the future of penile cancer management by improving diagnostic precision, treatment strategies, and patient outcomes. Literature has shown improved accuracy and quality of current AI models for the detection and treatment of penile cancer. Further research is required to understand its potential and limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.